Company Profile

Lazzaro Medical Inc
Profile last edited on: 6/10/25      CAGE: 9GFH5      UEI: QYYXKK2PSJX9

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2023
First Award
2024
Latest Award
2024
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1215 Spruce
Boulder, CO 80302
   (866) 672-2800
   info@lazzaromed.com
   www.lazzaromed.com
Location: Single
Congr. District: 02
County: Boulder

Public Profile

Tracheobronchomalacia, known as TBM, is a degenerative disease that causes the complete, or near-complete, collapse of the airway due to the breakdown of cartilage in the trachea. Often masquerading as chronic cough and/or shortness of breath, even after prescribed medications, it progressively worsens, often along with bouts of pneumonia and other respiratory infections. This leads to a significantly reduced quality of life, and even death, if left untreated.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1742212656 2 NIH $1,323,709
Project Title: Lazzaro Medical Scaffold System for improved treatment of tracheobronchomalacia

Key People / Management

  Dawn Bitz -- President

  James Polsen -- Chief Financial Officer

Company News

There are no news available.